Liu Y, Wu J, Ji Z, Chen L, et al. Comparative efficacy and safety of different combinations of three CDK4/6 inhibitors with endocrine therapies in HR+/HER-2 - metastatic or advanced breast cancer patients: a network meta-analysis. BMC Cancer 2023;23:816.
PMID: 37653504